MIM 3.0 Radiology App Approved by FDA

MIM software announced that its radiology app Mobile MIM 3.0 has been approved by the US Food and Drug Administration

MIM software announced that its radiology app Mobile MIM 3.0 has been approved by the US Food and Drug Administration to be used in viewing images to plan for a radiation-based treatment.

The company said that the app provides a number of features for physicians who can use it to display volume histograms, isodose curves and contours along with the ability to consult with other physicians.

Lung Biopsy - Indications - Procedures - Risks - FAQs - Reference
The procedure by which tissue samples are obtained from the lung is known as lung biopsy. The biopsy tissues obtained from the lungs are examined by a pathologist.

Announcing FDA’s decision, MIM software’s director Jerimy Brockway said, “Making Mobile MIM intuitive for radiation oncology was a primary goal, and we focused on creating the most natural and streamlined experience possible. The feedback so far has been overwhelmingly positive.”

Source-Medindia

Lung Cancer - Types, Causes, Symptoms, Diagnosis, Treatment and Prevention
Lung cancer is a malignant tumor in the lung tissues. Smoking is the main cause of lung cancer with symptoms like recurrent respiratory diseases.

Lung Cancer Screening - FAQs
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible cure.